Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5274999
Max Phase: Preclinical
Molecular Formula: C51H51NO21
Molecular Weight: 1013.96
Associated Items:
ID: ALA5274999
Max Phase: Preclinical
Molecular Formula: C51H51NO21
Molecular Weight: 1013.96
Associated Items:
Canonical SMILES: CC(=O)Oc1cc(OC(C)=O)c2c(c1)O[C@H](c1cc(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c1)[C@H](OC(=O)c1cc(OC(C)=O)c(OCC(=O)N[C@@H](Cc3ccccc3)C(=O)OC(C)(C)C)c(OC(C)=O)c1)C2
Standard InChI: InChI=1S/C51H51NO21/c1-25(53)64-35-21-38(65-26(2)54)36-23-44(46(71-39(36)22-35)33-17-42(68-29(5)57)48(70-31(7)59)43(18-33)69-30(6)58)72-49(61)34-19-40(66-27(3)55)47(41(20-34)67-28(4)56)63-24-45(60)52-37(50(62)73-51(8,9)10)16-32-14-12-11-13-15-32/h11-15,17-22,37,44,46H,16,23-24H2,1-10H3,(H,52,60)/t37-,44+,46+/m0/s1
Standard InChI Key: RFWAHOFTHRNZPO-LHNWHIAQSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1013.96 | Molecular Weight (Monoisotopic): 1013.2954 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Lee H, Jeong JH, Lee T, Chong Y, Choo H, Lee S.. (2023) Identification of (-)-Epigallocateshin gallate derivatives promoting innate immune activation via 2',3'-cyclic GMP-AMP-stimulator of interferon genes pathway., 90 [PMID:37182610] [10.1016/j.bmcl.2023.129325] |
Source(1):